---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-012233"
form_type: "8-K"
ticker: "CPRX"
cik: "0001369568"
company_name: "CATALYST PHARMACEUTICALS, INC."
filed_at: "2025-01-24T23:59:59+00:00"
generated_at: "2026-05-27T10:38:08.039679+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Catalyst Pharma director O'Keeffe to retire; not standing for reelection at 2025 meeting

## Summary
- Charles B. O'Keeffe, 85, will not stand for reelection at the 2025 annual meeting; term ends at that meeting.
- O'Keeffe has served as independent director since 2004, currently Lead Independent Director.
- Retirement not due to any disagreement with company on operations, policies, or practices.
- Corporate Governance Committee will hire a recruitment firm to search for a replacement director.

## SEC filing metadata
- accession: 0001193125-25-012233
- form_type: 8-K
- ticker: CPRX
- cik: 0001369568
- company_name: CATALYST PHARMACEUTICALS, INC.
- filed_at: 2025-01-24T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1369568/000119312525012233/0001193125-25-012233-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1369568/000119312525012233/d911150d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-012233
- JSON: https://secwatch.observer/filing/0001193125-25-012233.json
- Plain text: https://secwatch.observer/filing/0001193125-25-012233.txt

## Key facts
- Executive change
  Charles B. O’Keeffe departed as Lead Independent Director at CATALYST PHARMACEUTICALS, INC..
  - Action: retire
  - Role: Lead Independent Director
  source text: On January 17, 2025, Charles B. O’Keeffe, an independent member of the Board of Directors (“Board”) of Catalyst Pharmaceuticals, Inc. (the “Company”), advised the Company of his decision to not stand for reelection at the 2025 annual meeting of the Company’s stockholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1369568/000119312525012233/0001193125-25-012233-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.